Latest Period
Q1 2026
Security Snapshot
PAVmed Inc. - Common Stock, $0.001 par value per share (PAVM) Institutional Ownership
CUSIP: 70387R403
13F Institutional Holders and Ownership History from Q4 2023 to Q1 2026
Institutions Reporting
0
Shares (Excl. Options)
0
Price
$0.24
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Symbol
- PAVM on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 0
- Total 13F value
- $0
- Share change
- -1,574,456
- Value change
- -$350,669
- Number of holders
- 0
- Shares outstanding
- 6,578,769
- SEC-reported price per share
- $0.24
Latest holder snapshot
4 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- PAVM - PAVmed Inc. - Common Stock, $0.001 par value per share is tracked under CUSIP 70387R403.
- 0 institutions reported positions in Q1 2026.
- 10 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 27 to 0 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $426,481 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 0 institutions filings for Q1 2026.
Security key
70387R403
Latest holder period
Q1 2026
13F holders
0
13D/G owners
10
CIK / CUSIP context first
Open Q1 2026 holders
PAVM full holder history
PAVmed Inc. SEC filings
PAVmed Inc. company facts
PAVmed Inc. insider transactions
PAVmed Inc. 13D/G history
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 70387R403:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
10
Security
PAVM
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Sargent Investment Group, LLC | 5.8% | $604,183 | 1,006,300 | Sargent Investment Group, LLC | 01 Jul 2025 | |||
| Tasso Partners, LLC | 15% | -19% | $215,114 | -$353,303 | 974,246 | -62% | Dana Carrera | 27 Mar 2026 |
| Ayrton Capital LLC | 10% | +0.9% | $170,177 | -$124,139 | 709,069 | -42% | Ayrton Capital LLC | 31 Mar 2026 |
| Two Seas Capital LP | 10% | $157,733 | 657,219 | Two Seas Capital LP | 31 Mar 2026 | |||
| FIRST MANHATTAN CO. LLC. | 9.6% | +132% | $153,406 | -$17,978 | 639,191 | -10% | FIRST MANHATTAN CO. LLC. | 31 Mar 2026 |
| Scopia Holdings LLC | 9.9% | $140,798 | 637,670 | Matthew Sirovich | 27 Mar 2026 | |||
| NAGELBERG DAVID S | 8.6% | $120,770 | 546,964 | NAGELBERG DAVID S | 27 Mar 2026 | |||
| Kallman Craig | 6% | $84,923 | 384,616 | Kallman Craig | 27 Mar 2026 | |||
| Aklog Lishan | 5.1% | $81,490 | 369,068 | Aklog Lishan | 02 Apr 2026 | |||
| Dols Scott V. | 5.4% | $76,431 | 346,155 | Dols Scott V. | 27 Mar 2026 |
As of 31 Mar 2026, 0 institutional investors reported holding 0 shares of PAVmed Inc. - Common Stock, $0.001 par value per share (PAVM). This represents 0% of the company’s total 6,578,769 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
10
Latest
Q1 2026
Rows shown
1-10 of 10
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 0 | $0 | -$350,669 | $0.24 | 0 |
| 2025 Q4 | 1,917,493 | $426,481 | +$27,422 | $0.22 | 27 |
| 2025 Q3 | 1,535,145 | $662,767 | +$133,813 | $0.43 | 32 |
| 2025 Q2 | 1,224,831 | $735,397 | +$3,569 | $0.60 | 29 |
| 2025 Q1 | 1,211,515 | $873,492 | +$123,620 | $0.72 | 30 |
| 2024 Q4 | 1,041,798 | $653,834 | -$49,628 | $0.63 | 25 |
| 2024 Q3 | 1,120,689 | $1,378,717 | +$95,825 | $1.23 | 22 |
| 2024 Q2 | 1,056,670 | $861,151 | +$57,582 | $0.82 | 23 |
| 2024 Q1 | 952,389 | $2,032,208 | +$362,293 | $2.14 | 22 |
| 2023 Q4 | 753,692 | $3,104,938 | +$3,104,938 | $4.12 | 25 |